Leveraged & Inverse Channel Top Performing Leveraged/Inverse ETFs: 09/11/2022 By Sneha ShahSeptember 13, 2022
Leveraged & Inverse Channel Top Performing Leveraged/Inverse ETFs: 06/26/2022 By Sneha ShahJune 29, 2022
Leveraged & Inverse Channel Top Performing Leveraged/Inverse ETFs: 11/07/2021 By Sneha ShahNovember 9, 2021
Leveraged & Inverse Channel 3 ETFs to Access a Changing Pharmaceutical Industry By Ben HernandezAugust 16, 2021
Leveraged & Inverse Channel PILL Hasn’t Been a Bitter ETF to Swallow The Past Month By Ben HernandezDecember 23, 2020
Leveraged & Inverse Channel Direxion to Change Indexes For Leveraged Pharma, Real Estate ETFs By Tom LydonJune 4, 2019
Beyond Basic Beta Channel 4 ETFs to Consider with Big Pharma on the Senate’s Hot Seat By Ben HernandezApril 9, 2019
Leveraged & Inverse Channel Big Biopharma Mergers Could Fuel These ETFs in 2019 By Ben HernandezJanuary 10, 2019
Leveraged & Inverse Channel Pharma Earnings: The PILL to CURE Market Troubles? By DirexionNovember 1, 2018
Featured Direxion Debuts Double Leveraged Cyber Security, Pharmaceuticals ETFs By Tom LydonSeptember 16, 2015
